Title: | Basic & clinical pharmacology |
Author Name: | Bertram G Katzung and Anthony J. Trevor. |
Author Sur Name: | KATZUNG, Bertram G. |
Author information: |
|
Edition/Published: | 13th ed. _New Delhi : McGrawHill , 2015 |
New to this edition: |
|
Physical Description: xii, 1204p., : <p>ill., tables. graphs</p>.; 27.5cm. ...( A LANGE medical book ) |
Notes | Includes Bibliographical References and Indexes. |
Bibliography: | Severel Pages |
Includes Index: | P. 1141-1204 |
ISBN No's: | 978-93-392-2077-8 , 978-93-392-2077-8 |
Bar Code's: | , |
Shelf Location's: | 47 , |
Classification | |
Subject: | Clinical Pharmacology |
Dewey Class No: | 615.1 |
Letter Call No: | Ka16b |
LC Classification: | RM301.28 2015 |
Other's Book Information | |
Book ID No: | 1717 , 1716 |
Total Books: | 2 |
Date of collection's: | 01-Nov-2016 , 01-Nov-2016 |
Donation / Purchase: | Purchase |
Language: | English |
Status: | Available |
Department: | Pharmacology |
Synopsis: |
|
Review: |
|
Description: |
|
Key Features: |
|
Summary: |
Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. |
Abstract: |
Organized to reflect the course sequence in many pharmacology courses and in integrated curricula, Basic & Clinical Pharmacology covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors’ many years of experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. |
Preface: |
The thirteenth edition of Basic & Clinical Pharmacology continues the important changes inaugurated in the eleventh edition, with extensive use of full-color illustrations and expanded coverage of transporters, pharmacogenomics, and new drugs. Case studies accompany most chapters and answers to questions posed in the case studies appear at the end of each chapter. As in prior editions, the book is designed to provide a comprehensive, authoritative, and readable pharmacology textbook for students in the health sciences. Frequent revision is necessary to keep pace with the rapid changes in pharmacology and therapeutics; the 2–3 year revision cycle of the printed text is among the shortest in the field and the availability of an online version provides even greater currency. The book also offers special features that make it a useful reference for house officers and practicing clinicians. Information is organized according to the sequence used in many pharmacology courses and in integrated curricula: basic principles; autonomic drugs; cardiovascular-renal drugs; drugs with important actions on smooth muscle; central nervous system drugs; drugs used to treat inflammation, gout, and diseases of the blood; endocrine drugs; chemotherapeutic drugs; toxicology; and special topics. This sequence builds new information on a foundation of information already assimilated. For example, early presentation of autonomic nervous system pharmacology allows students to integrate the physiology and neuroscience they have learned elsewhere with the pharmacology they are learning and prepares them to understand the autonomic effects of other drugs. This is especially important for the cardiovascular and central nervous system drug groups. However, chapters can be used equally well in courses and curricula that present these topics in a different sequence. Within each chapter, emphasis is placed on discussion of drug groups and prototypes rather than offering repetitive detail about individual drugs. Selection of the subject matter and the order of its presentation are based on the accumulated experience of teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. Major features that make this book particularly useful in integrated curricula include sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects—in other words, clinical pharmacology is an integral part of this text. Lists of the trade and generic names of commercial preparations available are provided at the end of each chapter for easy reference by the house officer or practitioner writing a chart order or prescription. Significant revisions in this edition include: Addition of a chapter on pharmacogenomics, an area of increasing importance in all aspects of pharmacology. The drug development and regulation material previously covered in Chapter 5 has been incorporated into Chapter 1. A generic name–trade name table appears at the conclusion of most chapters, providing a rapid reference for these names. Many revised illustrations in full color provide significantly more information about drug mechanisms and effects and help to clarify important concepts. Major revisions of the chapters on sympathomimetic, diuretic, antipsychotic, antidepressant, antidiabetic, anti-inflammatory, and antiviral drugs, prostaglandins, nitric oxide, hypothalamic and pituitary hormones, central nervous system neurotransmitters, immunopharmacology, and toxicology. Continued expansion of the coverage of general concepts relating to newly discovered receptors, receptor mechanisms, and drug transporters. Descriptions of important new drugs released through August 2014. An important related educational resource is Katzung & Trevor's Pharmacology: Examination & Board Review, tenth edition (Trevor AJ, Katzung BG, & Masters SB: McGraw-Hill, 2013). This book provides a succinct review of pharmacology with approximately one thousand sample examination questions and answers. It is especially helpful to students preparing for board-type examinations. A more highly condensed source of information suitable for review purposes is USMLE Road Map: Pharmacology, second edition (Katzung BG, Trevor AJ: McGraw-Hill, 2006). This edition marks the 32th year of publication of Basic & Clinical Pharmacology. The widespread adoption of the first twelve editions indicates that this book fills an important need. We believe that the thirteenth edition will satisfy this need even more successfully. Spanish, Portuguese, Italian, French, Indonesian, Japanese, Korean, Turkish, and Ukrainian translations are available. Translations into other languages are under way; the publisher may be contacted for further information. I wish to acknowledge the prior and continuing efforts of my contributing authors and the major contributions of the staff at Lange Medical Publications, Appleton & Lange, and McGraw-Hill, and of our editors for this edition, Donna Frassetto and Rachel D'Annucci Henriquez. I also wish to thank Alice Camp and Katharine Katzung for their expert proofreading contributions. Suggestions and comments about Basic & Clinical Pharmacology are always welcome. They may be sent to me in care of the publisher. Bertram G. Katzung, MD, PhD San Francisco December, 2011 |
Content: |
SECT ION I BASIC PRINCIPLES 1. Introduction: The Nature of Drugs & Drug Development & Regulation Bertram G. Katzung, MD, PhD 2. Drug Receptors & Pharmacodynamics Mark von Zastrow, MD, PhD 3. Pharmacokinetics & Pharmacodynamics: Rational Dosing & the Time Course of Drug Action Nicholas H. G. Holford, MB, ChB, FRACP 4. Drug Biotransformation Maria Almira Correia, PhD 5. Pharmacogenomics Jennifer E. Hibma, PharmD, & Kathleen M. Giacomini, PhD SECT ION II AUTONOMIC DRUGS 6. Introduction to Autonomic Pharmacology Bertram G. Katzung, MD, PhD 7. Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs Achilles J. Pappano, PhD 8. Cholinoceptor-Blocking Drugs Achilles J. Pappano, PhD 9. Adrenoceptor Agonists & Sympathomimetic Drugs Italo Biaggioni, MD, & David Robertson, MD 10. Adrenoceptor Antagonist Drugs David Robertson, MD, & Italo Biaggioni, MD SECT ION III CARDIOVASCULAR-RENAL DRUGS 11. Antihypertensive Agents Neal L. Benowitz, MD 12. Vasodilators & the Treatment of Angina Pectoris Bertram G. Katzung, MD, PhD 13. Drugs Used in Heart Failure Bertram G. Katzung, MD, PhD 14. Agents Used in Cardiac Arrhythmias Joseph r. Hume, PhD, & Augustus O. Grant, MD, PhD 15. Diuretic Agents Ramin Sam, MD, David Pearce, MD, & Harlan E. Ives, MD, PhD SECT ION IV DRUGS WITH IMPORTANT ACTIONS ON SMOOTH MUSCLE 16. Histamine, Serotonin, & the Ergot Alkaloids Bertram G. Katzung, MD, PhD 17. Vasoactive Peptides Ian A. Reid, PhD 18. The Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, & Related Compounds Emer M. Smyth, PhD, & Garret A. FitzGerald, MD 19. Nitric Oxide Samie R. Jaffrey, MD, PhD 20. Drugs Used in Asthma Joshua M. Galanter, MD, & Homer A. Boushey, MD SECT ION V DRUGS THAT ACT IN THE CENTRAL NERVOUS SYSTEM 21. Introduction to the Pharmacology of CNS Drugs John A. Gray, MD, PhD, & Roger A. Nicoll, MD 22. Sedative-Hypnotic Drugs Anthony J. Trevor, PhD 23. The Alcohols Susan B. Masters, PhD, & Anthony J. Trevor, PhD 24. Antiseizure Drugs Roger J. Porter, MD, & Brian s. Meldrum, MB, PhD 25. General Anesthetics Helge Eilers, MD, & Spencer Yost, MD 26. Local Anesthetics Kenneth Drasner, MD 27. Skeletal Muscle Relaxants Marieke Kruidering-Hall, PhD, & Lundy Campbell, MD 28. Pharmacologic Management of Parkinsonism & Other Movement Disorders Michael J. Aminoff, MD, DSc, FRCP 29. Antipsychotic Agents & Lithium Charles DeBattista, MD 30. Antidepressant Agents Charles DeBattista, MD 31. Opioid Agonists & Antagonists Mark A. Schumacher, PhD, MD, Allan I. Basbaum, PhD, & Ramana K. Naidu, MD 32. Drugs of Abuse Christian Lüscher, MD SECT ION VI DRUGS USED TO TREAT DISEASES OF THE BLOOD, INFLAMMATION, & GOUT 33. Agents Used in Cytopenias; Hematopoietic Growth Factors James L. Zehnder, MD 34. Drugs Used in Disorders of Coagulation James L. Zehnder, MD 35. Agents Used in Dyslipidemia Mary J. Malloy, MD, & John P. Kane, MD, PhD 36. Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Nonopioid Analgesics, & Drugs Used in Gout Nabeel H. Borazan, MD, & Daniel E. Furst, MD SECT ION VII ENDOCRINE DRUGS 37. Hypothalamic & Pituitary Hormones Roger K. Long, MD, & Hakan Cakmak, MD 38. Thyroid & Antithyroid Drugs Betty J. Dong, PharmD, FASHP, FCCP, & Francis S. Greenspan, MD, FACP 39. Adrenocorticosteroids & Adrenocortical Antagonists George P. Chrousos, MD 40. The Gonadal Hormones & Inhibitors George P. Chrousos, MD 41. Pancreatic Hormones & Antidiabetic Drugs Martha S. Nolte Kennedy, MD, & Umesh Masharani, MBBS, MRCP (UK) 42. Agents That Affect Bone Mineral Homeostasis Daniel D. Bikle, MD, PhD SECT ION VIII CHEMOTHERAPEUTIC DRUGS 43. Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics Daniel H. Deck, PharmD, & Lisa G. Winston, MD 44. Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones Daniel H. Deck, PharmD, & Lisa G. Winston, MD 45. Aminoglycosides & Spectinomycin Daniel H. Deck, PharmD, & Lisa G. Winston, MD 46. Sulfonamides, Trimethoprim, & Quinolones Daniel H. Deck, PharmD, & Lisa G. Winston, MD 47. Antimycobacterial Drugs Daniel H. Deck, PharmD, & Lisa G. Winston, MD 48. Antifungal Agents Don Sheppard, MD, & Harry W. Lampiris, MD 49. Antiviral Agents Sharon Safrin, MD 50. Miscellaneous Antimicrobial Agents; Disinfectants, Antiseptics, & Sterilants Daniel H. Deck, PharmD, & Lisa G. Winston, MD 51. Clinical Use of Antimicrobial Agents Harry W. Lampiris, MD, & Daniel S. Maddix, PharmD 52. Antiprotozoal Drugs Philip J. Rosenthal, MD 53. Clinical Pharmacology of the Antihelminthic Drugs Philip J. Rosenthal, MD 54. Cancer Chemotherapy Edward Chu, MD, & Alan C. Sartorelli, PhD 55. Immunopharmacology Douglas F. Lake, PhD, & Adrienne D. Briggs, MD SECT ION IX TOXICOLOGY 56. Introduction to Toxicology: Occupational & Environmental Daniel T. Teitelbaum, MD 57. Heavy Metal Intoxication & Chelators Michael J. Kosnett, MD, MPH 58. Management of the Poisoned Patient Kent R. Olson, MD SECT ION X SPECIAL TOPICS 59. Special Aspects of Perinatal & Pediatric Pharmacology Gideon Koren, MD 60. Special Aspects of Geriatric Pharmacology Bertram G. Katzung, MD, PhD 61. Dermatologic Pharmacology Dirk B. Robertson, MD & Howard I. Maibach, MD 62. Drugs Used in the Treatment of Gastrointestinal Diseases Kenneth R. McQuaid, MD 63. Therapeutic & Toxic Potential of Over-the-Counter Agents Robin L. Corelli, PharmD 64. Dietary Supplements & Herbal Medications Cathi E. Dennehy, PharmD, & Candy Tsourounis, PharmD 65. Rational Prescribing & Prescription Writing Paul W. Lofholm, PharmD, & Bertram G. Katzung, MD, PhD 66. Important Drug Interactions & Their Mechanisms John R. Horn, PharmD, FCCP Appendix: Vaccines, Immune Globulins, & Other Complex Biologic Products Harry W. Lampiris, MD, & Daniel S. Maddix, PharmD Index |